Market competition influences renal transplantation risk and outcomes

Annals of Surgery

Volumn 260, Issue 3, 2014, Pages 550-557

  Adler, Joel T ^a,b   Sethi, Rosh K V ^b   Yeh, Heidi ^b,c   Markmann, James F ^b,c   Nguyen, Louis L ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

disparities; market competition; renal transplantation

Indexed keywords

ADULT; DONOR; ECONOMIC ASPECT; ECONOMICS; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; TRANSPLANTATION; UNITED STATES;

ADULT; ECONOMIC COMPETITION; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; UNITED STATES;

EID: 84906061869     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000896     Document Type: Conference Paper

References (14)

1. Yeh H, Smoot E, Schoenfeld DA, et al. Geographic inequity in access to livers for transplantation. Transplantation. 2011;91:479-486.
2. Axelrod DA, Guidinger MK, Finlayson S, et al. Rates of solid-organ waitlisting, transplantation, and survival among residents of rural and urban areas. JAMA. 2008;299:202-207.
3. Halldorson JB, Paarsch HJ, Dodge JL, et al. Center competition and outcomes following liver transplantation. Liver Transpl. 2012;19:96-104.
4. Smith JM, Biggins SW, Haselby DG, et al. Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant. 2012;12:3191-3212.
5. Rao PS, Schaubel DE, Guidinger MK, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation. 2009;88:231-236.
6. Garonzik-Wang JM, James NT, Weatherspoon KC, et al. The aggressive phe-notype: center-level patterns in the utilization of suboptimal kidneys. Am J Transplant. 2012;12:400-408.
7. Garonzik-Wang JM, James NT, Van Arendonk KJ, et al. The aggressive phe-notype revisited: utilization of higher-risk liver allografts. Am J Transplant. 2013;13:936-942.
8. Bazzoli GJ, Marx D, Arnould RJ, et al. Federal antitrust merger enforcement standards: a good fit for the hospital industry? J Health Polit Policy Law. 1995;20:137-169.
9. Cutler DM, Scott Morton F. Hospitals, market share, and consolidation. JAMA. 2013;310:1964-1970.
10. Sethi RKV, Henry AJ, Hevelone ND, et al. Impact of hospital market competition on endovascular aneurysm repair adoption and outcomes. J Vasc Surg. 2013;58:596-606.
11. OPO Specific Reports. Scientific Registry of Transplant Recipients' Web site. Available at http://www.srtr.org/opo/default.aspx. Published September 6, 2013. Accessed November 12, 2013.
12. Mathur AK, Ashby VB, Sands RL, et al. Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation. Am J Transplant. 2010;10:1069-1080.
13. Arce CM, Goldstein BA, Mitani AA, et al. Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol. 2013;8:2149-2157.
14. Chang DC, Shiozawa A, Nguyen LL, et al. Cost of inpatient care and its association with hospital competition. J Am Coll Surg. 2011;212:12-19.